Hamazaki K, Gochi A, Shimamura H, Kaihara A, Maruo Y, Doi Y, Orita K, Lygidakis N J
First Department of Surgery, Okayama University Medical School.
Hepatogastroenterology. 1996 Jan-Feb;43(7):229-34.
BACKGROUND/AIMS: This is a comparative study of the relationship between.
Serum levels of circulating intercellular adhesion molecule-1 (cICAM-1) were measured by ELISA assay in four patients with chronic hepatitis (CH), 16 with liver cirrhosis (LC), 38 with hepatocellular carcinoma (HCC), and in nine healthy controls.
No significant difference in cICAM-1 levels was observed between LC and HCC. The cICAM-1 level in HCC did not correlate with tumor markers but correlated well with tumor size. cICAM-1 level in HCC Stage III + IV was significantly higher than that of Stage I, and was higher in HCC with liver metastasis as opposed to HCC without metastasis. Furthermore, the cICAM-1 level of HCC decreased significantly after hepatectomy.
These findings showed a close relationship between cICAM-1 and the progress of intrahepatic metastasis of HCC, indicating a possibility for using cICAM-1 as a prognostic marker.
背景/目的:这是一项关于[具体关系]的对比研究。
采用酶联免疫吸附测定法(ELISA)检测4例慢性肝炎(CH)患者、16例肝硬化(LC)患者、38例肝细胞癌(HCC)患者及9名健康对照者血清中循环细胞间黏附分子-1(cICAM-1)的水平。
LC组与HCC组的cICAM-1水平无显著差异。HCC患者的cICAM-1水平与肿瘤标志物无关,但与肿瘤大小密切相关。HCCⅢ + Ⅳ期的cICAM-1水平显著高于Ⅰ期,有肝转移的HCC患者的cICAM-1水平高于无转移者。此外,肝切除术后HCC患者的cICAM-1水平显著降低。
这些结果表明cICAM-1与HCC肝内转移进展密切相关,提示cICAM-1有可能作为一种预后标志物。